Showing results (231-240 of 393) with videos related to
Sort By:
Pageof 40
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|June 1, 1993
[Thrombolytic therapy of acute myocardial infarct--current status and new developments]C Bode, G Schuler, E von Hodenberg, et al.Chemistry and Physics of Lipids|January 1, 1994
Effects of lipoprotein(a) on thrombolysisE von Hodenberg, E Pestel, J Kreuzer, et al.Proceedings of the National Academy of Sciences of the United States of America|March 1, 1990
Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylaseJ D McDonald, V C Bode, W F Dove, et al.Genetics|February 1, 1988
hph-1: a mouse mutant with hereditary hyperphenylalaninemia induced by ethylnitrosourea mutagenesisV C Bode, J D McDonald, J L Guenet, et al.Thrombosis and Haemostasis|March 1, 2000
Plasminogen activator inhibitor type-1 (PAI-1) and its role in cardiovascular diseaseT K Nordt, K Peter, J Ruef, et al.Thrombosis and Haemostasis|March 1, 2000
Pharmacokinetics and pharmacodynamics of lanoteplase (n-PA)T K Nordt, M Moser, B Kohler, et al.Basic Research in Cardiology|May 1, 2001
4-hydroxynonenal induces apoptosis, NF-kappaB-activation and formation of 8-isoprostane in vascular smooth muscle cellsJ Ruef, M Moser, C Bode, et al.Zeitschrift Fur Kardiologie|January 1, 1993
Combinations of thrombolytic agents in acute myocardial infarctionC Bode, H Baumann, E von Hodenberg, et al.Klinische Wochenschrift|October 3, 1990
Gastric emptying in non-responders to H2-receptor antagonistsS Walker, J Meinke, U Klotz, et al.Deutsche Medizinische Wochenschrift (1946)|February 21, 1986
[Vipoma. 9-year observations using currently available therapy methods]K Zimmermann, T Rapp, J Binder, et al.Pageof 40